Deficiency of p38α‐MAPK in myeloid cells, but not only in microglia, efficiently attenuates cerebral Aβ and improves cognitive function in APP‐transgenic Alzheimer's disease mice. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.